| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -558.5% |
| ROCE | 470.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-22 | n/a | (6.27) | (0.56)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-23 | 5.27 | (14.30) | (1.50)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-24 | n/a | (9.12) | (0.68)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-25 | 4.71 | (15.30) | (1.26)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-26 | n/a | (20.23) | (1.73)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-27 | 2.31 | (12.89) | (1.16)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Issue of Equity, Director Dealing & Voting Rights | 15-Oct-2026 | 07:00 | RNS |
| Preliminary Results | 09-Oct-2026 | 07:00 | RNS |
| Notice of GM | 02-Oct-2026 | 07:00 | RNS |
| /C O R R E C T I O N -- KushoAI/ | 02-Apr-2026 | ShareCast |
| FDA clears Scancell's application for phase thre... | 26-Jan-2026 | ShareCast |
| Scancell reports further data from DNA cancer im... | 09-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 9.33p |
| Change Today | -0.025p |
| % Change | -0.27 % |
| 52 Week High | 26.25 |
| 52 Week Low | 9.30 |
| Volume | 216,260 |
| Shares Issued | 1,212.23m |
| Market Cap | £113.04m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 08:58 | 304 @ 9.30p |
| 08:58 | 284 @ 9.30p |
| 08:56 | 279 @ 9.30p |
| 08:56 | 319 @ 9.30p |
| 08:55 | 274 @ 9.30p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research